There are 2867 resources available
Invited Discussant 1447O and 1448O
Presenter: Andre Fay
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Slides
Webcast
Invited Discussant 652O and 653O
Presenter: Lisa Licitra
Session: Proffered Paper session: Head & neck cancer
Resources:
Slides
Webcast
Invited Discussant 317MO, 318MO and 319MO
Presenter: Clara Montagut Viladot
Session: Mini Oral session: GI, lower digestive
Resources:
Slides
Webcast
Invited Discussant LBA71 and 931MO
Presenter: Luis Paz-Ares
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant 1490MO and 1491MO
Presenter: Herbert Ho Fung Loong
Session: Mini Oral session: Sarcoma
Resources:
Slides
Webcast
Invited Discussant 625MO, 626MO and 627MO
Presenter: Maria Gomes da Silva
Session: Mini Oral session: Haematological malignancies
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Head & neck cancer
Resources:
Slides
Webcast
320MO - A phase I clinical trial of regorafenib, ipilimumab, and nivolumab (RIN) in chemotherapy resistant MSS metastatic colorectal cancer (mCRC)
Presenter: Marwan Fakih
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast
929MO - Platform study of neoadjuvant durvalumab (D) alone or combined with novel agents in patients (pts) with resectable, early-stage non-small cell lung cancer (NSCLC): Pharmacodynamic correlates and circulating tumor DNA (ctDNA) dynamics in the NeoCOAST study
Presenter: Jonathan Spicer
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast